Genenta Science
GNTA
4 hedge funds and large institutions have $2.73M invested in Genenta Science in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
898% more capital invested
Capital invested by funds: $274K → $2.73M (+$2.46M)
100% more funds holding
Funds holding: 2 → 4 (+2)
2.27% more ownership
Funds ownership: 0.25% → 2.52% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$2.45M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.15K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank Julius Baer & Co
Zurich,
Switzerland
| $2.46M | +$2.45M | +412,547 | New |
|
|
AU
2
Algebris (UK)
London,
United Kingdom
| $267K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $4.13K | +$4.15K | +700 | New |
|
4
Morgan Stanley
New York
| $2.95K | – | – | – |
|
GNTA Hedge Fund Activity: Q2 2023 in Review
4 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q2 2023, worth a combined $2.73M — up 898% from $274K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GNTA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank Julius Baer & Co, opening a new position worth an estimated $2.45M.
- 4 institutional investors held Genenta Science (GNTA) as of Q2 2023, up from 2 in Q1 2023.
- Funds reported $2.73M of Genenta Science stock for Q2 2023, up 898% quarter-over-quarter.
- 2 funds opened new Genenta Science positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest Genenta Science buyer in Q2 2023 was Bank Julius Baer & Co, an estimated $2.45M added.
Based on aggregated 13F filings for Q2 2023.